Which Stock Worth Selling? Comp En De Mn Cemig ADS (CIG) or Boston Scientific Corporation (BSX)

The shares of Comp En De Mn Cemig ADS (NYSE:CIG) and Boston Scientific Corporation (NYSE:BSX) were among the active stocks of the last trading sessions. Comp En De Mn Cemig ADS (NYSE:CIG) declined to -3.59% closing at the price of $2.95 whereas the shares of Boston Scientific Corporation (NYSE:BSX) soared 1.29% with the increase of 0.49 points closing at the price of $38.44. Comp En De Mn Cemig ADS has currently increase 35.94% in its stock over the period of 6-months while its rival Boston Scientific Corporation added 28.26% in the previous 6-months.

Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.

Returns and Profitability

Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.

The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Comp En De Mn Cemig ADS (NYSE:CIG) is 7% while the ROI of Boston Scientific Corporation (NYSE:BSX) is 10.4%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, CIG’s EBITDA Margin is 7.43 whereas BSX’s is 21.83.

Both the profitability ratios suggest that Boston Scientific Corporation (NYSE:BSX) is more suitable investment in terms of profitability and return.

EPS & Surprise Factor

Comp En De Mn Cemig ADS (NYSE:CIG) reported $-0.01/share EPS for the previous quarter where analysts were predicting an EPS to be $0.06/share Thus lagging the analyst Estimates with a Surprise Factor of -116.7 Percent. While, Boston Scientific Corporation (NYSE:BSX) reported EPS of $0.35/share in the last quarter. The analysts projected EPS of $0.34/share depicting a Surprise of 2.9 Percent.

Taking a look at Earnings per Share, Boston Scientific Corporation tends to be beating the analyst estimates more than Comp En De Mn Cemig ADS. so BSX is more profitable than CIG.

Technical Analysis of Comp En De Mn Cemig ADS & Boston Scientific Corporation

Moving average convergence divergence (MACD) shows that Comp En De Mn Cemig ADS (NYSE:CIG) is on a PRICE RELATIVITY trend While Boston Scientific Corporation (NYSE:BSX) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Comp En De Mn Cemig ADS was in BEARISH territory and Boston Scientific Corporation was in BULLISH territory.

CIG’s current statistics gauge that the stock candle is BEARISH with LOW volatility. While BSX’s candle is BULLISH with HIGH.

EPS Growth Rate: CIG’s 0% versus BSX’s 10.7%

Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Comp En De Mn Cemig ADS (NYSE:CIG) is predicted at 0% while Boston Scientific Corporation (NYSE:BSX) stands at 10.7%. These numbers suggest that BSX is more suitable investment in terms of EPS growth rate.

Financial Risk and Liquidity Concerns

The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of CIG stands at 0.9 while BSX is at 0.8 whereas the debt ratio of the prior is 1 while the debt ratio of the later is 0.8.

The values of the both ratios suggest that CIG is more suitable investment when the liquidity and risk is the main concern.

Analyst Recommendations

While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2 for CIG and 1.5 for BSX which means CIG has Buy rating whereas BSX has Buy rating.

Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for CIG is $3.03 which is 2.64% of its current price while BSX has price target of 41.88 which is 8.21% of its current price.

Valuation Ratios

Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.

CIG currently has price to earning P/E ratio of 15.28 whereas BSX has 35.23 while the forward P/E ratio for the prior stands at 11.01 and for the later it depicts the value of 24.39.

The price to Book P/B for CIG is 1.08, Price to Sale is at 0.71 and for BSX these ratios stand at 6.42 and 5.53.